Skip to main content

amlodipine,valsartan and hydrochlorothiazide

NDC 33342-286 · Macleods Pharmaceuticals Limited

Generic nameamlodipine,valsartan and hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE, VALSARTAN, HYDROCHLOROTHIAZIDE
Strength10; 25; 160 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

33342-286-07 — 30 TABLET, FILM COATED in 1 BOTTLE (33342-286-07)

33342-286-10 — 90 TABLET, FILM COATED in 1 BOTTLE (33342-286-10)

33342-286-12 — 10 BLISTER PACK in 1 CARTON (33342-286-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-245 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-246 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-247 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-279 — amlodipine and valsartan, 33342-280 — amlodipine and valsartan, 33342-281 — amlodipine and valsartan, 33342-282 — amlodipine and valsartan, 33342-283 — amlodipine,valsartan and hydrochlorothiazide, 33342-284 — amlodipine,valsartan and hydrochlorothiazide, 33342-285 — amlodipine,valsartan and hydrochlorothiazide, 33342-287 — amlodipine,valsartan and hydrochlorothiazide, 33342-467 — Triamterene and Hydrochlorothiazide, 33342-570 — Sacubitril and Valsartan, 33342-571 — Sacubitril and Valsartan, 33342-572 — Sacubitril and Valsartan, 35356-807 — hydrochlorothiazide, 42291-001 — Amlodipine and Olmesartan Medoxomil, 42291-002 — Amlodipine and Olmesartan Medoxomil, 42291-003 — Amlodipine and Olmesartan Medoxomil, 42291-004 — Amlodipine and Olmesartan Medoxomil, +1568 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels